Research and Markets: Colorectal Cancer - KOL Insight Module

The global market for colorectal cancer drugs is undergoing a fundamental shift due to wider generic competition in cytotoxics and increasing adoption of anti-EGFR products as first line therapies.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131125005868&newsLang=en&ndmConfigId=1000639&vnsId=41